Ponatinib cancer drug molecule. Tyrosine kinase inhibitor used in treatment of chronic myeloid leukemia CML and acute. #187947141
Description
Ponatinib cancer drug molecule. Tyrosine kinase inhibitor used in treatment of chronic myeloid leukemia CML and acute lymphoblastic leukemia ALL. Skeletal formula